Home/Bio Usawa Biotechnology/Richard Chin, MD
RC

Richard Chin, MD

Co‑founder, Chair of Scientific Committee, Board Chairman

Bio Usawa Biotechnology

Therapeutic Areas

Bio Usawa Biotechnology Pipeline

DrugIndicationPhase
Rituximab BiosimilarNon‑Hodgkin LymphomaPreclinical
Trastuzumab BiosimilarHER2‑Positive Breast CancerPreclinical
Bevacizumab BiosimilarVarious Solid TumorsPreclinical